跳至主要内容
临床试验/NCT03578172
NCT03578172已完成不适用

Randomized, Controlled Trial to Assess the Efficacy of Human Menopausal Gonadotrophin Stimulation and Hormone Replacement Therapy for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe Intrauterine Adhesion Patients

Reproductive & Genetic Hospital of CITIC-Xiangya1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2018年7月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
186
试验地点
1
主要终点
Ongoing pregnancy rate

研究概览

简要总结

Evaluation of endometrial preparation using either human menopausal gonadotrophin (HMG) stimulation and hormone replacement therapy (HRT) prior to blastocyst transfer in patients with moderate to severe intrauterine adhesion (IUA).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • BMI 18~23 kg/m2
  • Women with moderate to severe IUA as defined by the American Fertility Society classification (1988)
  • Presence of at least 3 cryopreserved cleavage-stage embryos (including 1 good quality) or blastocysts

排除标准

  • Using embryos from donor oocytes
  • Preimplantation genetic diagnosis(PGD)/Preimplantation genetic screening(PGS) cycles
  • Moderate or severe endometriosis
  • Untreated unilateral or bilateral hydrosalpinx
  • Uterine adenomyosis, uterine myoma (submucous,intramural myoma >4 cm),>1cm septate uterus, double uterus, bicornuate uterus, unicornuate uterus

研究组 & 干预措施

Experimental-HMG stimulation group

Experimental

Women will be subjected to ovarian stimulation for endometrial preparation using human menopausal gonadotrophin before blastocyst transfer

干预措施: human menopausal gonadotrophin (Drug)

Control-HRT group

Active Comparator

Women will be subjected to hormone replacement therapy for endometrial preparation before blastocyst transfer

干预措施: hormone replacement therapy (Drug)

结局指标

主要结局

Ongoing pregnancy rate

时间窗: 10th week after embryo transfer

Ongoing pregnancy is defined as the presence of a gestational sac with foetal heartbeat by transvaginal ultrasound at 10th week after embryo transfer(ET)

次要结局

  • Cycle cancellation rate(the day of embryo transfer)
  • Implantation rate(4th weeks after embryo transfer)
  • Clinical pregnancy rate(4th weeks after embryo transfer)
  • Biochemical pregnancy rate(4th weeks after embryo transfer)
  • Early miscarriage rate(12th weeks gestational age)

研究者

发起方
Reproductive & Genetic Hospital of CITIC-Xiangya
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验